Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingxin Pang

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Oncology Reports|November 16, 2012
Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivoHong Luan Mao, Yingxin Pang, Xiaolei Zhang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 23, 2014
DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathwayYingxin Pang, Manfei Si, Bin Sun, et al.
Cancer Letters|April 23, 2011
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cellsGuangmin Xi, Xiaoyan Hu, Baolin Wu, et al.
Cancer Management and Research|March 4, 2021
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial CarcinomaQianhan Lin, Xiaoxue Ma, Shunxue Hu, et al.
Oncotargets and Therapy|October 22, 2019
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian CancerWenqing Luan, Yingxin Pang, Rui Li, et al.
Talanta|April 27, 2025
A biosensor based on tetrahydroxyborate-bismuth vanadate for early diagnosis towards lncRNA markers in cervical cancer tumorsCong Cong, Rui Liu, Yue Sun, et al.
Journal of Translational Medicine|July 28, 2022
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancerYingxin Pang, Gaigai Bai, Jing Zhao, et al.
Frontiers in Oncology|September 24, 2021
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS PathwayXuan Wei, Juanjuan Shi, Qianhan Lin, et al.
FEMS Yeast Research|March 11, 2021
Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeabilityMing Zhang, Jinghui Lu, Ximeng Duan, et al.
Disease Markers|July 26, 2021
GABPA Expression in Endometrial Carcinoma: A Prognostic MarkerXiaoxue Ma, Qianhan Lin, Gongting Cui, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncology Reports|November 16, 2012
Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivoHong Luan Mao, Yingxin Pang, Xiaolei Zhang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 23, 2014
DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathwayYingxin Pang, Manfei Si, Bin Sun, et al.
Cancer Letters|April 23, 2011
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cellsGuangmin Xi, Xiaoyan Hu, Baolin Wu, et al.
Cancer Management and Research|March 4, 2021
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial CarcinomaQianhan Lin, Xiaoxue Ma, Shunxue Hu, et al.
Oncotargets and Therapy|October 22, 2019
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian CancerWenqing Luan, Yingxin Pang, Rui Li, et al.
Talanta|April 27, 2025
A biosensor based on tetrahydroxyborate-bismuth vanadate for early diagnosis towards lncRNA markers in cervical cancer tumorsCong Cong, Rui Liu, Yue Sun, et al.
Journal of Translational Medicine|July 28, 2022
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancerYingxin Pang, Gaigai Bai, Jing Zhao, et al.
Frontiers in Oncology|September 24, 2021
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS PathwayXuan Wei, Juanjuan Shi, Qianhan Lin, et al.
FEMS Yeast Research|March 11, 2021
Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeabilityMing Zhang, Jinghui Lu, Ximeng Duan, et al.
Disease Markers|July 26, 2021
GABPA Expression in Endometrial Carcinoma: A Prognostic MarkerXiaoxue Ma, Qianhan Lin, Gongting Cui, et al.
Pageof 4